Cargando…

Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system

Detalles Bibliográficos
Autor principal:	Hida, Toyoaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483074/ https://www.ncbi.nlm.nih.gov/pubmed/37691872 http://dx.doi.org/10.21037/tlcr-23-43

Ejemplares similares

Anaplastic Lymphoma Kinase Is Required for Neurogenesis in the Developing Central Nervous System of Zebrafish
por: Yao, Sheng, et al.
Publicado: (2013)

Primary Central Nervous System Anaplastic Large T-cell Lymphoma
por: Splavski, Bruno, et al.
Publicado: (2016)

ML-3 A Case of Primary Central Nervous System Anaplastic Lymphoma Kinase Positive Anaplastic Large cell Lymphoma at Neurohypophysis and Pineal Gland
por: Kohno, Shohei, et al.
Publicado: (2021)

Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?
por: Hida, Toyoaki, et al.
Publicado: (2020)

Clinical presentation of anaplastic large-cell lymphoma in the central nervous system
por: NOMURA, MASASHI, et al.
Publicado: (2013)

Primary central nervous system lymphoma
por: Gloghini, Annunziata, et al.
Publicado: (2015)

Localized Tacrolimus Delivery Repairs the Damaged Central Nervous System
por: Willerth, Stephanie Michelle
Publicado: (2017)

Be mindful of the central nervous system in Burkitt lymphoma
por: Roschewski, Mark
Publicado: (2021)

Inflammatory myofibroblastic tumors of the central nervous system that express anaplastic lymphoma kinase have a high recurrence rate
por: Denis, Daniel J., et al.
Publicado: (2013)

Anaplastic lymphoma kinase inhibitor-associated myositis
por: Uruha, Akinori, et al.
Publicado: (2020)

Anaplastic lymphoma kinase inhibitors and their effect on the kidney
por: Bonilla, Marco, et al.
Publicado: (2022)

Central nervous system tumors: Spotlight on India
por: Munshi, Anusheel
Publicado: (2016)

Engineered AAV vectors for improved central nervous system gene delivery
por: A Kotterman, Melissa, et al.
Publicado: (2015)

Addition of atezolizumab to nab-paclitaxel plus carboplatin is a new standard option for the first-line treatment for non-squamous non-small cell lung cancer
por: Yamaguchi, Teppei, et al.
Publicado: (2019)

Anaplastic large cell lymphoma: The evolution continues
por: Das, Dilip K
Publicado: (2011)

Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma
por: Subbiah, V., et al.
Publicado: (2021)

Central Nervous System (CNS) and Systemic Autoimmune Disease: Coexistence or More?
por: Vibha, Deepti, et al.
Publicado: (2022)

Cutaneous Anaplastic Large T-Cell Lymphoma with Invasion of the Central Nervous System: A Case Report
por: Seo, Hyun-Nam, et al.
Publicado: (2017)

Anaplastic lymphoma kinase: signalling in development and disease
por: Palmer, Ruth H., et al.
Publicado: (2009)

Primary Angiitis of the Central Nervous System: A Great Mimicker
por: Modi, Tanish, et al.
Publicado: (2022)

Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma
por: Janostiak, Radoslav, et al.
Publicado: (2019)

How we treat primary central nervous system lymphoma
por: Calimeri, T., et al.
Publicado: (2021)

COVID‐19 infection in primary central nervous system lymphoma treatment: Who is most at risk?
por: Lim, Sean H.
Publicado: (2022)

Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase
por: Mologni, Luca, et al.
Publicado: (2022)

Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma
por: Xu, Tianqi, et al.
Publicado: (2019)

Primary anaplastic large cell lymphoma of the central nervous system in a child: A case report
por: Feng, Shuo, et al.
Publicado: (2020)

Alectinib Monotherapy in Isolated Central Nervous System Relapse of ALK-Positive Anaplastic Large Cell Lymphoma
por: Verran, Julian, et al.
Publicado: (2022)

Central nervous system and Cryptococcus neoformans
por: Gaona-Flores, Veronica A.
Publicado: (2013)

Primary gastric anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma
por: Tian, Chen, et al.
Publicado: (2016)

Penetrating the central nervous system sanctuary of KRAS, a target once thought “undruggable”
por: Nagasaka, Misako, et al.
Publicado: (2023)

Primary Central Nervous System ALK Positive Anaplastic Large Cell Lymphoma with Predominantly Leptomeningeal Involvement in an Adult
por: Park, Jae Sung, et al.
Publicado: (2013)

Central nervous system relapse in a child with anaplastic large cell lymphoma: potential for new therapeutic strategies
por: Raffa, Enass H., et al.
Publicado: (2021)

Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
por: Magaki, Shino, et al.
Publicado: (2021)

Anaplastic lymphoma kinase gene rearrangements in patients with advanced-stage non-small-cell lung cancer: CT characteristics and response to chemotherapy
por: Park, Jangchul, et al.
Publicado: (2014)

Mechanotransduction mechanisms in central nervous system glia
por: Cullimore, Brenan, et al.
Publicado: (2022)

Leukemic manifestation of anaplastic lymphoma kinase-negative-type anaplastic large-cell lymphoma
por: Kim, Jae Wook, et al.
Publicado: (2012)

Anaplastic Lymphoma Kinase in Cutaneous Malignancies
por: Cao, Severine, et al.
Publicado: (2017)

Targeting anaplastic lymphoma kinase in neuroblastoma
por: Umapathy, Ganesh, et al.
Publicado: (2019)

Anaplastic Lymphoma Kinase Inhibitor-Induced Neutropenia: A Systematic Review
por: Moinard-Butot, Fabien, et al.
Publicado: (2023)

The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor
por: Chen, Yating, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ve31fchhprta0cltkkht4o7c15